RACK1 and cancer: Apart from the lymphatic invasion/N+ stage, no correlation between RACK1 and the remaining clinicopathological features (age, gender, T stage, M stage, TNM stage, differentiation, tumor size, and nerve invasion) was observed, implying that RACK1 might contribute to the poor prognosis of patients with cancer primarily by promoting lymphatic invasion.